Similar articles

• [New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].

  Shiraki M. Shiraki M. Nihon Rinsho. 2007 Nov 28;65 Suppl 9:447-53. Nihon Rinsho. 2007. PMID: 18161147 Review. Japanese. No abstract available.
• [New bone density conservation agents for osteoporosis under research and development: Zoledronate].

  Wada S, Fukawa T, Kamiya S. Wada S, et al. Nihon Rinsho. 2007 Nov 28;65 Suppl 9:421-5. Nihon Rinsho. 2007. PMID: 18161143 Review. Japanese. No abstract available.
• [New bone density conservation agents for osteoporosis under research and development: Minodronic acid].

  Takata S. Takata S. Nihon Rinsho. 2007 Nov 28;65 Suppl 9:417-20. Nihon Rinsho. 2007. PMID: 18161142 Review. Japanese. No abstract available.
• Bone density vs bone quality: what's a clinician to do?

  Licata A. Licata A. Cleve Clin J Med. 2009 Jun;76(6):331-6. doi: 10.3949/ccjm.76a.08041. Cleve Clin J Med. 2009. PMID: 19487553 Review.
• [Perspective for development of parathyroid hormone and related compounds as therapeutic agents for osteoporosis].

  Ikeda K, Fukagawa M. Ikeda K, et al. Nihon Rinsho. 2005 Oct;63 Suppl 10:367-71. Nihon Rinsho. 2005. PMID: 16279664 Review. Japanese. No abstract available.